Confluent IPO Presentation Deck

Improving Leverage While Investing for Growth S&M as % of Revenue (Non-GAAP) Total Opex as % of Revenue (Non-GAAP) 121% 108% 119% 112% FY'19 FY'20 Q1'20 Q1'21 -53% -38% -53% -41% Non-GAAP Operating Margin Note: Refer to the slides in the section titled "GAAP to Non-GA ALS 35% R&D as % of Revenue Gurk (Non-GAAP) 30% 35% 27% FY'19 FY'20 QT20 Q1'21 Mennonce 73% 64% 71% 69% FY'19 FY'20 Q1'20 Q1'21 G&A as % of Revenue (Non-GAAP) 14% 13% 14% 16% 1-GAAP Reconciliations at the end of this presentation for a reconciliation of our non-GAAP financial matrics to the most directly comparable GAAP financial metrics. FY'19 FY'20 Q120 Q1'21

View entire presentation